Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Buske

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
Blood Advances|November 27, 2019
The ParaHox gene Cdx4 induces acute erythroid leukemia in miceSilvia Thoene, Tamoghna Mandal, Naidu M Vegi, et al.
Oncotarget|December 10, 2017
<i>Protein phosphatase 4 regulatory subunit 2 (PPP4R2)</i> is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repairJulia K Herzig, Lars Bullinger, Alpaslan Tasdogan, et al.
Oncotarget|November 27, 2016
VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in miceEva Gentner, Naidu M Vegi, Medhanie A Mulaw, et al.
The Journal of Clinical Investigation|July 19, 2005
The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in miceChristina Schessl, Vijay P S Rawat, Monica Cusan, et al.
Nuklearmedizin. Nuclear Medicine|January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and ChallengesRudolf Werner, Alexander Haug, Christian Buske, et al.
Blood|March 19, 2015
Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphomaDunja Schneider, Marcus Dühren-von Minden, Alabbas Alkhatib, et al.
Blood|November 10, 2016
Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminusMonica Cusan, Naidu M Vegi, Medhanie A Mulaw, et al.
The Lancet. Haematology|July 18, 2017
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trialWon Seog Kim, Christian Buske, Michinori Ogura, et al.
Blood|July 21, 2012
High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemiaKlaus H Metzeler, Bernhard Heilmeier, Katrin E Edmaier, et al.
Seminars in Hematology|May 29, 2025
Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk diseasePrashant Kapoor, Meletios A Dimopoulos, Stephen M Ansell, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Blood Advances|November 27, 2019
The ParaHox gene Cdx4 induces acute erythroid leukemia in miceSilvia Thoene, Tamoghna Mandal, Naidu M Vegi, et al.
Oncotarget|December 10, 2017
<i>Protein phosphatase 4 regulatory subunit 2 (PPP4R2)</i> is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repairJulia K Herzig, Lars Bullinger, Alpaslan Tasdogan, et al.
Oncotarget|November 27, 2016
VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in miceEva Gentner, Naidu M Vegi, Medhanie A Mulaw, et al.
The Journal of Clinical Investigation|July 19, 2005
The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in miceChristina Schessl, Vijay P S Rawat, Monica Cusan, et al.
Nuklearmedizin. Nuclear Medicine|January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and ChallengesRudolf Werner, Alexander Haug, Christian Buske, et al.
Blood|March 19, 2015
Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphomaDunja Schneider, Marcus Dühren-von Minden, Alabbas Alkhatib, et al.
Blood|November 10, 2016
Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminusMonica Cusan, Naidu M Vegi, Medhanie A Mulaw, et al.
The Lancet. Haematology|July 18, 2017
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trialWon Seog Kim, Christian Buske, Michinori Ogura, et al.
Blood|July 21, 2012
High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemiaKlaus H Metzeler, Bernhard Heilmeier, Katrin E Edmaier, et al.
Seminars in Hematology|May 29, 2025
Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk diseasePrashant Kapoor, Meletios A Dimopoulos, Stephen M Ansell, et al.
Pageof 15